Find the right doctor.Get information about our new institute structure.my health. MyChart.Find the right doctor.

Inderjit Gill, M.D.

Print this Content
Email this Content
Appointed: 1999
Gender: Male
Languages: English
Thoracic and Cardiovascular Surgery (Fairview)
Phone:(216) 476-7310
Location:Fairview Hospital
Mail Code Fairview
18099 Lorain Avenue
Fairview, OH 44111
Thoracic and Cardiovascular Surgery (MetroHealth Medical Center)
Phone:(216) 476-7310
Location:MetroHealth Medical Center
Mail Code Fairview
2500 MetroHealth Drive
Cleveland , OH 44109
 
 
Biographical Sketch

Inderjit Gill, MD, is a Staff cardiothoracic surgeon with the Cleveland Clinic's Heart Center at Cleveland Clinic's main campus, and serves as the Director of the Departments of Thoracic and Cardiovascular Surgery at Fairview Hospital and at the MetroHealth Medical Center. His specialty interests include the surgical treatment of adult acquired heart disease, minimally invasive surgery, off-pump coronary bypass surgery, surgery of the aorta and robotic cardiac surgery.

Dr. Gill received his medical degree from Christian Medical College and Brown Memorial Hospital in Punjab, India. He completed his surgical residency in the United Kingdom at Colchester General Hospital, which is an affiliate of the St. Thomas Hospital at the University of London. He was awarded a Cleveland Clinic Fellowship in cardiovascular surgery in the Department of Cardiothoracic Surgery and then completed an approved residency in cardiothoracic surgery from the University of Ottawa Heart Institute where he was then given a staff appointment and was a tenured assistant professor. Dr. Gill pioneered the technique of minimally invasive cardiac surgery in Canada. He joined Cleveland Clinic as an attending staff cardiothoracic surgeon in 1999.

Dr. Gill has been a principal site investigator in a number of clinical research trials including the POEM trial ,which was the first multicenter, randomized trial comparing off-pump surgery with conventional bypass, and a multicenter FDA approved trial to use Robotic assistance for coronary anastomosis. The first coronary anastomosis using the ZeusTM system in Ohio was completed successfully in August 2001.

Dr. Gill serves as an editorial reviewer for professional journals, such as The Annals of Thoracic Surgery, Circulation, The Canadian Journal of Cardiology, and The Journal of Thoracic and Cardiovascular Surgery. He has presented and published extensively on topics related to minimally invasive coronary surgery and on delayed operative intervention in the management of traumatic descending thoracic aortic rupture in major international meetings and journals.

Dr. Gill is a charter member of the International Society of Minimally Invasive Cardiac Surgery, the Canadian Society of Cardiac Surgeons, the Society of Critical Care Medicine, the Canadian Cardiovascular Society, the Society of Thoracic Surgeons and the Indian Association of Cardiothoracic Surgeons.

Dr. Gill is a Fellow of the Royal College of Surgeons of Ireland and a Fellow of the Royal College of Surgeons of England. He holds a specialist certificate in cardiothoracic surgery from the Royal College of Physicians and Surgeons of Canada. Dr. Gill holds medical licensures in Ohio and Ontario. He is a Fellow of the American College of Surgeons.

Education & Fellowships
Medical School:Punjab University, Christian Medical College Ludhiana, Punjab, India
 
Internship:Christian Medical College & Brown Memorial Hospital, Rotating, Ludhiana, Punjab, India
Residency:University of Ottawa Heart Institute, Cardiothoracic Surgery, Ottawa, Ontario, Canada
Fellowship:University of Ottawa Heart Institute, Cardiothoracic Surgery, Ottawa, Ontario, Canada
Fellowship:Cleveland Clinic, Cardiovascular Surgery, Cleveland, OH
Certifications

Royal College of Physicians & Surgeons of Canada - Cardiothoracic Surgery

Specialty Interests
Surgical treatment of adult acquired heart disease, minimally invasive surgery off pump bypass, surgery of the aorta, robotic cardiac surgery.
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/7/2008, Dr. Gill has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)